The authors identified polymorphisms predicting individual HCC susceptibility in high-risk HBV and HCV patients, such as ERCC1, GSTP1, CYP17A1, XRCC3 and ABCB1. These findings could contribute to HCC surveillance and early detection (181). The gene discussed is CYP17A1; the disease is hepatocellular carcinoma.